Colchicine NDC 72189-249

NDC codes

FDA NDC Directory

Product NDC (as listed)72189-249Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72189-0249Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72189-249-03	72189024903	3 TABLET, FILM COATED in 1 BOTTLE (72189-249-03)Marketed from Jul 23, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Colchicine
Generic name (nonproprietary): colchicine
Active ingredients: Colchicine — .6 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: direct rx
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022352
Marketing start: Jul 23, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Alkaloids (Chemical structure)
Identifiers: Product ID 72189-249_2c28c181-51d4-7164-e063-6394a90a1d0cSPL ID 2c28c181-51d4-7164-e063-6394a90a1d0cSPL set ID c7d013b7-0a67-0953-e053-2a95a90ac47cRxCUI 197541UNII SML2Y3J35T
Pharmacologic class: Alkaloid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472189024903 followed by a unit qualifier and the quantity

Package 72189-0249-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 20, 2025.

Indications (excerpt from the label)

1.1 Gout Flares Colchicine Tablets, USP are indicated for prophylaxis and the treatment of acute gout flares. Prophylaxis of Gout Flares: Colchicine Tablets, USP are indicated for prophylaxis of gout flares. Treatment of Gout Flares: Colchicine Tablets, USP are indicated for treatment of acute gout flares when taken at the first sign of a flare. 1.2 Familial Mediterranean Fever (FMF) Colchicine Tablets, USP are indicated in adults and children four years or older for treatment of familial Mediterranean fever (FMF).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 022352

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 022352
Product	Strength	Form · route	Labeler	Product NDC
Colchicine	Colchicine .6 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	63629-2166
Colchicine	Colchicine .6 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	63629-2167
Colchicine	Colchicine .6 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-1802
Colcryscolchicine	Colchicine .6 mg/1	Tablet, Film coatedOral	Proficient Rx LP	63187-292